Cell identity, count, and viability for critical quality attributes using the Cellaca® PLX image cytometer Carolina Franco Nitta, Mackenzie Pierce, Tim Smith, Marek Dobrowolski,Srinivas Gundimeda, Bo Lin, Dmitry Kuksin, and Leo Li-Ying Chan Cell and Gene therapy is one of the fastest growing fields of cancertherapeutics that heavily relies on robust and consistentinstrumentations and technologies to verify and validate fit-for purpose critical quality attributes (CQA). Some of the keyparameters required for satisfying CMC (Chemistry Manufacturingand Controls) criteria standards for cellular therapeutic products arecell identity, count, viability, purity, potency, stability, andmicrobiological quality, which may be routinely performed usingflow cytometry. Some of [...]